Website Search
ID 2026

Testing for Alzheimer’s disease

Professor Kenneth Kosik explains that Alzheimer's disease is traditionally diagnosed by a physician taking a history and physical. In the near future, neuroimaging will provide an accurate diagnosis.
Testing for Alzheimer’s disease can be a little bit difficult but the approaches are improving very, very rapidly. The best way we have now to actually test remains to do the classical work that physicians have done for a long time – that is to simply get a history and physical. From a history and physical, that is a history of slow and insidious decline in cognition (and when I say ‘slow’ I mean over years not over weeks), if you begin to get that history then suspicion rises greatly. But to move from the point of suggestive to actually being quite certain that the disease is Alzheimer’s, one needs some laboratory testing, one needs to do a scan, and then we can get upwards of 90% probability that the person has Alzheimer’s disease. One more point is that in the very near future, probably within the next year perhaps, we, as a field, have developed the ability to actually image in living people the senile plaques. Diagnosis will probably move from the 90% level of certainty up to really approaching 100%.
alzheimer, alzheimer's, accurate diagnosis, senile plaques, physicians, neuroimaging, kenneth, kosic
Creative Commons License This work by Cold Spring Harbor Laboratory is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.

Related content:

2025. What is Alzheimer's disease?
Professor Kenneth Kosik defines Alzheimer's disease as a slowly progressing illness that deteriorates the brain and impairs many major cognitive functions.
2028. Senile plaques and Alzheimer's disease
Professor Kenneth Kosik describes senile plaques, an extracellular collection of a-beta protein. It is one of the hallmarks of Alzheimer's disease.
2033. Amyloid precursor protein and Alzheimer's disease
Professor Kenneth Kosik describes the relationship between the amyloid precursor protein (APP) and Alzheimer’s disease. APP mutations are linked to early-onset Alzheimer’s disease.
2029. Neurofibrillary tangles and Alzheimer's disease
Professor Kenneth Kosik discusses neurofibrillary tangles, which form inside a cell and are made up of a protein called tau. There is a strong relationship with plaques and amyloid deposition.
2035. Acetylcholine and Alzheimer's disease
Professor Kenneth Kosik discusses the biochemistry of Alzheimer's disease in relation to acetylcholine and cholinergic deficiency.
2227. Alzheimer's disease
An overview of Alzheimer's disease-related content on Genes to Cognition Online.
2335. Amyloid Plaques - Hall mark of Alzheimer's Disease
Doctor Brian Bacskai discusses how Amyloid plaques lead to a definitive diagnosis of alzheimer's disease.
1289. Alzheimer's Disease - Nanotechnology Diagnosis
Bio-barcode amplification (BCA) is a new technique that can search for biological markers of Alzheimer's disease, which may lead to earlier diagnosis.
2187. Alzheimer's disease - imaging test
Professor Donna Wilcock discusses a new biological technique for diagnosing Alzheimer's disease using PET neuroimaging.
2032. Neuropathology of Alzheimer's disease
Professor Kenneth Kosik discusses some of the brain regions specifically associated with Alzheimer's disease, including the hippocampus, amygdala, and entorhinal cortex.
Cold Spring Harbor Laboratory
CSHL HomeAbout CSHLResearchEducationPublic EventsNewsstandPartner With UsGiving